Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Dennert

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Clinical and Vaccine Immunology : CVI|June 15, 2012
Differences in virus prevalence and load in the hearts of patients with idiopathic dilated cardiomyopathy with and without immune-mediated inflammatory diseasesRobert Dennert, Pieter van Paassen, Petra Wolffs, et al.
Antiviral Therapy|April 14, 2010
Intravenous immunoglobulin therapy for patients with idiopathic cardiomyopathy and endomyocardial biopsy-proven high PVB19 viral loadRobert Dennert, Sebastiaan Velthuis, Simon Schalla, et al.
European Heart Journal|October 30, 2010
Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failureGaetano M De Ferrari, Harry J G M Crijns, Martin Borggrefe, et al.
Journal of the American College of Cardiology|September 19, 2015
Prognostic Relevance of Gene-Environment Interactions in Patients With Dilated Cardiomyopathy: Applying the MOGE(S) ClassificationMark R Hazebroek, Suzanne Moors, Robert Dennert, et al.
Circulation. Heart Failure|March 16, 2018
Prevalence of Pathogenic Gene Mutations and Prognosis Do Not Differ in Isolated Left Ventricular Dysfunction Compared With Dilated CardiomyopathyMark R Hazebroek, Ingrid Krapels, Job Verdonschot, et al.
BMJ Open|July 8, 2021
Identification of anatomic risk factors for acute coronary events by optical coherence tomography in patients with myocardial infarction and residual nonflow limiting lesions: rationale and design of the PECTUS-obs studyJan-Quinten Mol, Anouar Belkacemi, Rick Hja Volleberg, et al.
Atherosclerosis|September 6, 2024
Sex differences in plaque characteristics of fractional flow reserve-negative non-culprit lesions after myocardial infarctionRick H J A Volleberg, Jan-Quinten Mol, Anouar Belkacemi, et al.
JAMA Cardiology|September 13, 2023
Fractional Flow Reserve-Negative High-Risk Plaques and Clinical Outcomes After Myocardial InfarctionJan-Quinten Mol, Rick H J A Volleberg, Anouar Belkacemi, et al.
The American Journal of Cardiology|June 11, 2016
Cardiac Troponin T and I Release After a 30-km RunLieke J J Klinkenberg, Peter Luyten, Noreen van der Linden, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Clinical and Vaccine Immunology : CVI|June 15, 2012
Differences in virus prevalence and load in the hearts of patients with idiopathic dilated cardiomyopathy with and without immune-mediated inflammatory diseasesRobert Dennert, Pieter van Paassen, Petra Wolffs, et al.
Antiviral Therapy|April 14, 2010
Intravenous immunoglobulin therapy for patients with idiopathic cardiomyopathy and endomyocardial biopsy-proven high PVB19 viral loadRobert Dennert, Sebastiaan Velthuis, Simon Schalla, et al.
European Heart Journal|October 30, 2010
Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failureGaetano M De Ferrari, Harry J G M Crijns, Martin Borggrefe, et al.
Journal of the American College of Cardiology|September 19, 2015
Prognostic Relevance of Gene-Environment Interactions in Patients With Dilated Cardiomyopathy: Applying the MOGE(S) ClassificationMark R Hazebroek, Suzanne Moors, Robert Dennert, et al.
Circulation. Heart Failure|March 16, 2018
Prevalence of Pathogenic Gene Mutations and Prognosis Do Not Differ in Isolated Left Ventricular Dysfunction Compared With Dilated CardiomyopathyMark R Hazebroek, Ingrid Krapels, Job Verdonschot, et al.
BMJ Open|July 8, 2021
Identification of anatomic risk factors for acute coronary events by optical coherence tomography in patients with myocardial infarction and residual nonflow limiting lesions: rationale and design of the PECTUS-obs studyJan-Quinten Mol, Anouar Belkacemi, Rick Hja Volleberg, et al.
Atherosclerosis|September 6, 2024
Sex differences in plaque characteristics of fractional flow reserve-negative non-culprit lesions after myocardial infarctionRick H J A Volleberg, Jan-Quinten Mol, Anouar Belkacemi, et al.
JAMA Cardiology|September 13, 2023
Fractional Flow Reserve-Negative High-Risk Plaques and Clinical Outcomes After Myocardial InfarctionJan-Quinten Mol, Rick H J A Volleberg, Anouar Belkacemi, et al.
The American Journal of Cardiology|June 11, 2016
Cardiac Troponin T and I Release After a 30-km RunLieke J J Klinkenberg, Peter Luyten, Noreen van der Linden, et al.
Pageof 2